Investments in R&D infrastructure win EUR 8m in EU funds
LifeWatch, a EUR 3.3 million project intended for the purchase of equipment which will enable international research projects for monitoring and projecting the effects of global changes on biodiversity to be continued, will get EUR 2.6 million from the European Regional Development Fund.
The research infrastructure will enable the collection, processing and storage of data on biodiversity, the Government Office for Development and European Cohesion Policy said in a press release on Tuesday.
A bank of tissue samples, an analytical centre and a molecular laboratory with software for analysis of genetic diversity and genomics and biotechnology instruments will also be established as part of the project.
Eatris, a EUR 2.4 million project aimed at modernising research infrastructure serving for early phases of development of pharmaceuticals and development of the latest diagnostic methods and therapeutic approaches, will get EUR 1.6 million in EU funds.
The projects includes genome and metabolome technologies which are, due to their application-oriented nature, also called translational research. This will improve Slovenia's competitiveness as part of the European Research Area and European research infrastructures.
Also receiving EUR 4.2 million from the European Regional Development Fund is Elixir, a EUR 5.3 million project intended for boosting the national research capacity in life sciences. It will provide infrastructure for a more efficient transfer of new knowledge to healthcare and industries related to biological processes.
The infrastructure enables effective integration of consortium partners with related partners in other national infrastructures in natural sciences, life sciences and advanced computer technologies, the government office said.